|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.840 USD | +3.20% |
|
-.--% | - |
| 24-11-20 | Exscientia plc(NasdaqGS:EXAI) dropped from S&P Global BMI Index | CI |
| 24-11-20 | Recursion Pharmaceuticals, Exscientia Complete Business Combination | MT |
| Market Cap | 500M 670M 586M 541M 950M 63.93B 966M 6.48B 2.54B 31.48B 2.51B 2.46B 109B | P/E 2022 |
-4.55x | P/E 2023 | -4.28x |
|---|---|---|---|---|---|
| Enterprise Value | 156M 209M 183M 168M 296M 19.92B 301M 2.02B 790M 9.81B 783M 767M 33.91B | EV / Sales 2022 |
1.9x | EV / Sales 2023 | 14.2x |
| Free-Float |
36.87% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | +3.20% |
| 3 years | 3.8 |  | 9.12 |
| 5 years | 3.8 | | 30.38 |
| 10 years | 3.8 | | 30.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | 61 | 2024-06-05 | |
| Chief Tech/Sci/R&D Officer | - | 2022-04-30 | |
John Overington
CTO | Chief Tech/Sci/R&D Officer | - | 2024-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Mario Polywka
BRD | Director/Board Member | 63 | 2017-09-27 |
Robert Ghenchev
BRD | Director/Board Member | 43 | 2020-04-30 |
Elizabeth Crain
CHM | Chairman | 61 | 2024-02-11 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.20% | -.--% | -.--% | -22.50% | 633M | |
| +1.68% | +3.55% | +4.86% | +10.97% | 49.42B | |
| +0.72% | +1.93% | +424.51% | +624.25% | 40.34B | |
| +2.54% | +2.84% | +27.06% | -3.62% | 34.01B | |
| +0.31% | +4.16% | +23.87% | +59.76% | 33.56B | |
| -2.09% | -0.80% | +3.56% | +33.56% | 26.84B | |
| -0.63% | +2.85% | - | - | 17.22B | |
| +0.66% | -1.48% | +66.05% | +127.36% | 15.19B | |
| -23.90% | -18.84% | +55.47% | +53.83% | 13.96B | |
| +2.59% | +0.50% | +15.28% | +21.25% | 13.36B | |
| Average | -1.49% | +0.74% | +68.96% | +100.54% | 24.45B | |
| Weighted average by Cap. | -0.59% | +0.89% | +93.11% | +138.42% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 27.22M 36.51M 31.92M 29.45M 51.73M 3.48B 52.59M 353M 138M 1.71B 137M 134M 5.93B | 20.08M 26.93M 23.54M 21.72M 38.15M 2.57B 38.79M 260M 102M 1.26B 101M 98.91M 4.37B |
| Net income | -119M -159M -139M -128M -226M -15.19B -229M -1.54B -602M -7.48B -597M -585M -25.85B | -146M -196M -171M -158M -277M -18.67B -282M -1.89B -741M -9.19B -734M -719M -31.78B |
| Net Debt | -492M -660M -577M -532M -935M -62.92B -950M -6.37B -2.5B -30.98B -2.47B -2.42B -107B | -344M -461M -404M -372M -654M -44.02B -665M -4.46B -1.75B -21.67B -1.73B -1.7B -74.94B |
Employees
483
- Stock Market
- Stocks
- EXAI Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
